COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
批准号:
10621132
负责人:
TED ROSS
金额:
$222.94万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
已结题
起止时间:
2019-09-10 至 2023-05-14
关键词:
Animal ModelAnimalsCOVID-19 vaccineCommunicable DiseasesContractorContractsCoronavirusElderlyHumanImmuneImmune responseImmunityIndividualMucous MembraneNational Institute of Allergy and Infectious DiseaseRecording of previous eventsUnited States National Institutes of HealthVaccinatedVaccinesanti-influenzacoronavirus diseasedesignhigh riskhigh risk populationimmunogenicityinfluenza virus vaccineinnovationnext generationnovel vaccinesobese personpregnantprogramsresponseseasonal influenzastandard of careuniversal influenza vaccineuniversal vaccinevaccine developmentvaccine strategy
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The objective of this contract program is to support improvements in the immunogenicity and durability of seasonal influenza vaccines, SARS-COV-2 vaccines and the development of innovative influenza vaccine approaches that provide robust, durable, broadly protective mucosal and systemic anti-influenza immunity (“universal influenza vaccines”) and other emerging or reemerging infectious diseases.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10242598
-
项目类别:
-
资助金额:$1074.98万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10021763
-
项目类别:
-
资助金额:$800.0万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10788197
-
项目类别:
-
资助金额:$1070.0万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10621131
-
项目类别:
-
资助金额:$1018.84万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
CIVIC: University of Georgia Center for Influenza Vaccine Research in High Risk Populations
-
批准号:10455390
-
项目类别:
-
资助金额:$1227.56万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2
-
批准号:10287647
-
项目类别:
-
资助金额:$96.97万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2
-
批准号:10621133
-
项目类别:
-
资助金额:$6.11万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
COVID Supplement - COMPONENT A OF THE COLLABORATIVE INFLUENZA VACCINE INNOVATION CENTERS (CIVICS) PROGRAM TO DESIGN AND EVALUATE INNOVATIVE INFLUENZA VACCINE APPROACHES,
-
批准号:10285380
-
项目类别:
-
资助金额:$96.97万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
COVID supplement: A multi-site study seeking to study immune responses developed after infection with SARS-CoV-2
-
批准号:10455392
-
项目类别:
-
资助金额:$157.59万
-
财政年份:2019
-
负责人:TED ROSS
-
依托单位:
海外基金